Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers.

Alberto Hernando-Calvo,Alejandra Rezqallah,Eoghan Ruadh Malone,Omar Saavedra Santa Gadea,Anna Spreafico,Maria Vieito,Ilan Weinreb,Susana Aguilar,Anneli Eliason,J.D. Assaf,Angela Rodriguez,Coro Bescós,Katherine Lajkosz,Juan Lorente,Sarah Jennings,Enriqueta Felip,Elena Garralda,Lillian L. Siu,Aaron R. Hansen,Irene Brana

Molecular profiling and targeted agents in recurrent, metastatic salivary gland tumor (R/M SGT) patients (pts) treated at two academic centers.

2021

6081Background: Treatment selection based on actionable alterations (AAs) is an appealing strategy for pts with R/M SGT. The GEMS-001 study (NCT02069730) at Princess Margaret Cancer Centre (PM) and...

Keywords:

Internal medicine
Medicine
cancer centre
Oncology
Selection (genetic algorithm)
Salivary gland tumor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations